Virginia Paton

Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2

Dennis J. Slamon, Brian Leyland‐Jones, Steven Shak et al. · New England Journal of Medicine · 2001 · 11.4K citations · Full text

Multinational Study of the Efficacy and Safety of Humanized Anti-HER2 Monoclonal Antibody in Women Who Have HER2-Overexpressing Metastatic Breast Cancer That Has Progressed After Chemotherapy for Metastatic Disease

Melody Cobleigh, Charles L. Vogel, Debu Tripathy et al. · Journal of Clinical Oncology · 1999 · 2.8K citations

Cardiac Dysfunction in the Trastuzumab Clinical Trials Experience

Andrew D. Seidman, Clifford A. Hudis, Mary Kathryn Pierri et al. · Journal of Clinical Oncology · 2002 · 1.5K citations

Results From the Phase III Randomized Trial of Onartuzumab Plus Erlotinib Versus Erlotinib in Previously Treated Stage IIIB or IV Non–Small-Cell Lung Cancer: METLung

David R. Spigel, Martin J. Edelman, Kenneth J. O’Byrne et al. · Journal of Clinical Oncology · 2017 · 314 citations

Interferon Gamma-1b Compared with Placebo in Metastatic Renal-Cell Carcinoma

Martin Gleave, Mostafa Elhilali, Yves Fradet et al. · New England Journal of Medicine · 1998 · 310 citations · Full text